Proapoptotic activity of aflatoxin B1 and sterigmatocystin in HepG2 cells  by Liu, Yang et al.
Toxicology Reports 1 (2014) 1076–1086
Contents lists available at ScienceDirect
Toxicology  Reports
j ourna l h o mepa ge: www.elsev ier .com/ locate / toxrep
Proapoptotic  activity  of  aﬂatoxin  B1 and  sterigmatocystin
in  HepG2  cells
Yang  Liu,  Ming  Du,  Genyi  Zhang ∗
State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800, Lihu Avenue,
Wuxi 214122, Jiangsu Province, PR China
a  r  t  i c  l  e  i  n  f  o
Article history:
Received 31 July 2014
Received  in revised form 15 October 2014
Accepted 17 October 2014
Available  online 29 October 2014
Keywords:
Aﬂatoxin B1
Sterigmatocystin
Combinative toxicity
Apoptosis
a  b  s  t  r  a  c  t
Aﬂatoxin  B1 (AFB1)  and  sterigmatocystin  (ST)  are  two  hepatocarcinogenic  mycotoxins  that
are commonly  coexisted  in cereal  grains,  and  their  co-proapoptotic  activity  in HepG2  cells
was studied.  The  values  of  IC50, which  is the  dosage  of  mycotoxin  resulting  in  a  50%  cell
growth  inhibition  measured  by a sulforhodamine  B  (SRB)  colorimetric  assay,  were  16.9  M
and 7.3  M  for  AFB1 and  ST,  respectively.  Additively  and  dose-dependently,  cell apoptosis-
related  toxicity  endpoints  of double  strand  DNA  and  ATP  content  were  decreased  while  the
intracellular  ROS  and  mitochondria  membrane  permeability  (MMP)  were  increased.  Con-
sistently, when  cell  cycle  is arrest  at G0/G1  or S phase  by  AFB1 and/or  ST,  the experimental
results  from  ﬂow  cytometry  assay  demonstrated  that  the  rate  of cell  apoptosis  and  mito-
chondrial  membrane  potential  were  also  additively  increased  and  decreased,  respectively,
in  a dose-dependent  manner.  Thus,  the  integrity  of  mitochondria  (MMP  and  membrane
potential)  that  is the  central  component  of cell  apoptosis  is disrupted  by  AFB1 and  ST  in an
additive  manner.  With  the  immunocytochemistry  analysis  showing  increased  expression
of apoptosis-related  proteins  of  Bax, Caspase-3  and  p53  and  decreased  expression  of Bcl-2
protein,  an  additive  nature  of  the  co-proapoptotic  activity  of AFB1 and  ST  was  revealed.
©  2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
 BY-NCthe CC
1. Introduction
Aﬂatoxin (AF) is a class of mycotoxins mainly produced
by Aspergillus ﬂavus and Aspergillus parasiticus, and there
are  multiple types of aﬂatoxin including AFB1, AFB2, AFG1
and AFG2 with different structures and physiochemical
properties [1]. Among all these types of aﬂatoxin, AFB1
has shown to be the highest toxic agent [2] with its potent
genotoxic, hepatocarcinogenic [3], and reproductive
Abbreviations: ATCC, American type culture collection; AFB1, aﬂatoxin
B1; FCM, ﬂow cytometry assay; ST, sterigmatocystin; SRB, sulforhodamine
B; MMP, mitochondrial membrane permeability; PCA, principle compo-
nent analysis; PI, propidium iodide.
∗ Corresponding author. Tel.: +86 0510 85328726.
E-mail address: genyiz@163.com (G. Zhang).
http://dx.doi.org/10.1016/j.toxrep.2014.10.016
2214-7500/© 2014 The Authors. Published by Elsevier Ireland Ltd. Th
(http://creativecommons.org/licenses/by-nc-sa/3.0/).-SA  license  (http://creativecommons.org/licenses/by-nc-sa/3.0/).
toxicity [4]. The formation of reactive AFB1-epoxide by the
action  of cytochrome P450 enzymes is the central pathway
to  its genotoxicity [5]. Many animal studies conﬁrmed its
toxicity  with a LD50 between 0.3 and 17.9 mg/kg varied
by animal models. More importantly, the microorganisms
from Aspergillus genus are widely present in the natural
world, and AFB1 contamination has been shown in many
cereal  grains such as corn [6] and rice [7], and it has become
a  serious food-borne hazard. Although numerous detection
methods and technologies to eliminate AFB1 from food
ingredients have been developed, AFB1 contamination is
still  a major challenge to food industry and public health
since  aﬂatoxin contamination in food chains can occur at
any  stage of food production, processing, transport and
storage.
Co-exposure to multiple mycotoxins has become a pub-
lic  health concern since human body is rarely exposed to
is is an open access article under the CC BY-NC-SA license
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ne type of mycotoxin, and some mycotoxin combinations
ight produce a synergistic toxicity. The combinative tox-
city  of AFB1 with deoxynivalenol (DON) [8], T-2 [9], and
umonisin B1 [10] have been reported, and additive or
ynergistic interaction have been discovered in some com-
inations.  Sterigmatocystin (ST) and AFB1 – structurally
imilar mycotoxin with a bisdihydrofuran moiety (Fig. 1),
as  similar toxicity to AFB1 [11]. Both of them can inhibit
TP  synthesis [12] and impair cell cycle [13]. ST is also a
arcinogenic agent [14] and an adduct of 1,2-dihydro-2-
N(7)-guanyl)-1-hydroxysterigmatocystin can be formed
hrough  its reaction with DNA in an exo-ST-1,2-oxide struc-
ural  form [15]. Regarding the coexistence of AFB1 and ST,
here  have been reports that both of them are produced
y the same species, such as Emericella venezuelensis [16]
nd  Emericella astellata [17]. ST is also widely present in
ereal  grains of corn and food product of bread [18], and
heir  coexistence was also detected in urine from a human
tudy  [19]. Thus, coexistence of AFB1 and ST is present in
ature  and food chains. Although toxicities of AFB1 [10] and
T  [20] and their precursors [21] have been studied individ-
ally  and comparatively, their combinative toxicity related
o  cell apoptosis has not been fully investigated, and it is
orth  of further investigation from a mechanistic point of
iew  so that preventive or interventive measures can be
eveloped to ameliorate their in vivo toxic effects. Due to
he  hepatocarcinogenic property of both AFB1 and ST, the
uman  hepatoma HepG2 cell was used as the cell model
o  investigate their co-proapoptotic activity and related
echanisms, and it is expected that the basic toxicity prop-
rty  and mechanism obtained from a model system might
acilitate developing interventive measures to reduce their
ivo  toxicity to the body.
.  Materials and methods
.1.  Materials
Human hepatoma HepG2 cells lines were obtained from
merican Type Culture Collection (ATCC, Beijing, China).
FB1 (purity ≥ 98%), ST (purity ≥ 98%), DMSO, sulforho-
amine B (SRB), TCA, H33258, DCFH-DA, DCF, rhodamine
23, JC-1 dye, and calf thymus DNA were purchased from
igma–Aldrich (Shanghai, China). Dulbecco’s Modiﬁed
agle Medium (DMEM), fetal bovine serum (FBS), trypsin,
BSS,  and phosphate-buffered saline (PBS) were purchasedin B1 (B) sharing a common bisdihydrofuran moiety.
from  Gibco Life Technologies (Shanghai, China). ATP assay
kit,  Annexin V-FITC cell apoptosis assay kit, and mitochon-
dria membrane potential assay kit were obtained from
Beyotime Institute of Biotechnology (Shanghai, China). DAB
was  purchased from Genetech Inc. (Shanghai, China). All
the  antibodies for Caspase-3, p53, Bax and Bcl-2 were from
Germany AbioB, LTM. (Shanghai, China).
2.2. Cell culture
HepG2 cells were cultured in DMEM medium contain-
ing FBS (10%), penicillin (100 units/mL) and streptomycin
(100 g/mL) under a humidiﬁed incubator with CO2 (5%)
and  air (95%) at 37 ◦C. Every 5–7 days, the adherent
cells were suspended after treatment with 1 mL  of 0.25%
trypsin–EDTA solution for 2–3 min  at 37 ◦C, and then were
subcultured at a 1:3 split ratio. The culture medium was
changed every 2 days. Stocks of cells were routinely frozen
and  stored in liquid nitrogen. Cells with 15–20 passages
were used for experiments to ensure cell line stability.
2.3. Determination of cell viability
The cell viability was  measured by a sulforhodamine B
colorimetric assay (SRB) [22]. Brieﬂy, log phase HepG2 cells
(200  L) were seeded at a density of 3 × 104 cells/mL in a
96-well plate. After incubation for 24 h, culture medium
containing AFB1 or ST (dissolved in DMSO) was  used to treat
the  cells for 24 or 48 h. Then, the cells were ﬁxed by adding
100  L cold (4 ◦C) trichloroacetic acid (TCA) solution (10%
w/v)  and incubated at 4 ◦C for 1 h, and then gently washed
with deionized water four to ﬁve times. After the plate was
air-dried,  100 L SRB reagent (4 g/L) was  added and incu-
bated  at room temperature for 30 min, then the plate was
washed  with 1% acetic acid four to ﬁve times and air-dried.
The  OD reading at 490 nm was carried out by adding 200 L
10  mM Tris–HCl buffer (pH 7.4) to each well. Cell growth
inhibition rate in percentage was calculated by comparing
with the control sample (without AFB1 and ST treatment).
2.4. Cytotoxicity endpoint measurementHepG2 cells were seeded at a density of 5 × 104 cells/mL
in a 96-well plate. After the seeded cells were incubated
with AFB1 or ST for 24 h and 48 h, cytotoxicity endpoints of
ATP  and DNA content, ROS and mitochondria membrane
y Report1078 Y. Liu et al. / Toxicolog
permeability (MMP)  were measured to reﬂect the toxic
effect  of AFB1 and ST on HepG2 cells. Brieﬂy, the double
strand DNA content was measured using a H33258 reagent
after  cell lysis as described by Rage et al. [23]. Reactive
oxygen species (ROS) were measured by oxidation of dihy-
drodichloroﬂuorescein to dichloroﬂuorescein as described
in  literature [24]. Mitochondria membrane permeability
(MMP)  was measured by the uptake and retention of rho-
damine  123 as described by Rat et al. [25]. ATP content
was measured using the assay kit as described by the assay
manual.
2.5.  Flow cytometry assay (FCM)
A FCM (Becton, Dickinson and Company, New Jersey,
USA) was employed to examine the mitochondria mem-
brane  potential, cell cycle and apoptosis of HepG2 cell
after  treatment with AFB1 and ST. The mitochondria mem-
brane  potential ( m)  is measured using the JC-1 dye
as  described by literature report [26] by differentiation of
the  energized and de-energized mitochondria based on the
ﬂuorescent  color. The cell cycle analysis is based the pro-
pidium  iodide (PI) dye that can bind double strand DNA
[27],  and the analysis protocol detailed in literature [28]
was  followed. The cell apoptosis was analyzed by employ-
ing  staining reagent of PI and Annexin V-FITC as described
by  Vermes et al. [29].
2.6.  Immunocytochemistry analysis of HepG2 cell
apoptosis
In  order to analyze the proapoptotic activity of AFB1 and
ST  in HepG2 cells, the apoptotic signaling pathway was
also  analyzed by immunocytochemistry using apoptosis
related markers of Bax, Bcl-2, p53, and Caspase-3. HepG2
cells  at the logarithmic phase were collected at a density of
1  × 104 cells/mL. Sterile coverslips were added to a 24-well
culture plate and then cell suspension was added to allow
the  cells seeded on the slips. After the cells become adher-
ent,  medium containing AFB1, ST and their mixture was
added  (in triplicate). After 48 h incubation, the slips were
removed and ﬁxed in formalin for 20 min, and then air-
dried  at room temperature. The slips were then hydrated
through a gradient of ethanol (two times, 1 min) – 95%
ethanol (two times, 1 min) – 70% ethanol (one time, 1 min)
–  water washed out after 5 min. Endogenous peroxidase
activity was blocked by adding100 L hydrogen peroxide
and  incubating at room temperature for 15 min, then it was
washed  three times with PBS with 5 min  interval. The ﬁxed
slips  were then placed in a boiling antigen retrieval solution
for  15 min, incubated for 15 min, cooled out after the power
is  turned off and washed three times (5 min  interval) with
PBS.  Non-immune serum (100 L) from the same source
of  secondary antibody was added on each slip, incubated
at  37 ◦C for 20 min, then diluted serum (antibody) (50 L)
was  added (Bax 1:300, Bcl-2 1:250, Caspase-3 1:200, p53
1:200)  and incubated overnight at 4 ◦C. After incubation
for 1 h at room temperature, the slips were washed with
PBS  three times (each time 5 min). The labeled secondary
antibody (50 L) was added per slip, incubated at 37 ◦C
for  30 min, and washed with PBS three times (each time,s 1 (2014) 1076–1086
5  min). After this was done, DAB was  added to each slip and
observed  under a microscope, the staining was  terminated
immediately by washing the residual DAB liquid with water
when  yellow particles appears. Hematoxylin was  added to
react  for 30 s, then washed with water 5 min, and differ-
entiated by hydrochloride alcohol for 1 s and washed for
10  min. The coverslips were then dehydrated through a
gradient  of ethanol: 70% ethanol (one time, 3 min) – 95%
ethanol (two times, 3 min) – ethanol (one time, 3 min) –
xylene  (three times, 5 min). The air-dried coverslip was
mounted on a glass slide using a silicone–urethane adhe-
sive  reagent [30]. Bax, Bcl-2 proteins were localized in the
cytoplasm/nucleus showing brownish yellow. Caspase-3
protein positive results showed brown particles present in
the  cytoplasm with a blue nucleus. Brownish yellow nuclei
indicate  p53 protein positive results. Three horizons on
each  slide were selected to take pictures, and the mean
optical density of positive area was calculated using image
analysis  software of Image-Pro Plus 6.0 (Media Cybernetics,
Inc., Rockville, USA) based on the operation manual. Brieﬂy,
for  each protein, its speciﬁc color at speciﬁc locations was
clicked,  and the total intensity at the positive area (with
the  same color in deﬁned scope) was recorded and then the
optical  density (total intensity/area) was calculated auto-
matically.
2.7.  Statistic analysis
All  the data were expressed as average with standard
deviation. Probit analysis (StatsDirect Ltd., Cheshire, UK)
was  used to calculate the IC50 for AFB1 and ST. The
type of combinative toxicity is based on the method of
Weber  et al. [31] by comparing the measured cytotox-
icity with the calculated toxicity that was  obtained by
adding  the individual endpoint values at the same con-
centrations used in the combinative treatments, and the
statistic  difference between them (measured value and cal-
culated  value) was analyzed by unpaired t-test by SSPS
20.0  (IBM). If it is not statistically different at a signiﬁ-
cant level of p < 0.05, it is determined as additive toxicity.
If  it is different signiﬁcantly, it would be synergistic (mea-
sured  value > calculated value) or antagonistic (measured
value < calculated value). For other comparisons between
treatment and control groups, Student’s t-test was  used
while  paired t-test was applied when comparing different
groups. In the meantime, the principle component analy-
sis  (PCA) of the endpoints was  also conducted to cluster the
endpoints.
3.  Results and discussion
3.1.  Cytotoxicity of AFB1 and ST in HepG2 cells
For  cytotoxicity analysis, the IC50 is one important
parameter, and based on the dose-response relationship
(Fig. 2) measured by a SRB method, the IC50 were analyzed
to  be 16.9 M and 7.3 M for AFB1 and ST, respectively. For
AFB1, the cell growth was not affected signiﬁcantly at low
concentrations (<1 M)  while the cell was more sensitive
to  ST showing a linear inhibition of cell viability along its
concentrations. Apparently, ST is more toxic than AFB1 to
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eason  since low water solubility makes it easy to diffuse
nto  the cells. For AFB1, its high value of IC50 is different
rom literature reports measured by MTT  test [10], and
his  is likely due to different methods used to measure
ell viability. SRB refers to the total protein in the cell [22]
hile  MTT  test is based on the enzyme activity of NAD(P)H-
ependent cellular oxidoreductase [32], so there is possible
iscrepancy between the two methods, and the value of
ig. 3. The cytotoxicity endpoints after exposed to individual AFB1 and ST and t
omparing  to the control and expressed as percentage. SRB represents the cell gr2 cell viability affected by AFB1 and ST.
IC50 is likely dependent on the cell viability measurement
method. Regarding different values of IC50 between AFB1
and ST, there is a literature report that the IC50 of AFB1
(10 M)  is greater than that of ST (3.7 M)  in human lung
cancer cell line of A549 [10,33], which also showed that
ST  is more toxic than AFB . Another literature report [11]1
also  showed noticeable difference between AFB1 and ST
in  hormonal induction of tyrosine aminotransferase with
different  values of IC50 in a rat hepatoma cell line of H4-II-E.
heir combinations at different dosages. All the values were obtained by
owth inhibition rate.
1080 Y. Liu et al. / Toxicology Reports 1 (2014) 1076–1086
 ST and 
pared Fig. 4. The cell cycle distribution of HepG2 cells after exposed to AFB1,
(mol/L) and combination. * indicates signiﬁcant difference (p < 0.05) com
The cytotoxicity endpoints of ROS, mitochondria mem-
brane permeability (MMP), DNA and ATP content all
showed cytotoxicity of AFB1 and ST (Fig. 3) to HepG2 cells,
and  all the endpoints show similar trends when HepG2
cells  were exposed to individual AFB1 and ST or their com-
binations.their combination (AFB1 + ST). The legend represents the concentration
to the control.
The  contents of both ATP and DNA were decreased while
the  ROS and MMP  were increased along the treatment con-
centrations. Comparatively, the decrease of ATP and DNA
is  more evident than the increase of ROS and MMP, and
ST  is more potent to decrease ATP content. However, no
signiﬁcant difference between the measured combinative
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Fig. 5. The mitochondria membrane potential of HepG2 cells represented by th
exposed  to AFB1 and ST. * p < 0.05, ** p < 0.01 (statistic analysis was  compared to t
Table 1
Correlation analysis among all the endpoints (correlation coefﬁcient R and
p  values).
ATP DNA ROS MMP
DNA 0.636
0.0108*
ROS −0.686 −0.162
0.0047* 0.564
MMP −0.294 −0.278 0.293
0.2867 0.315 0.289
SRB −0.695 −0.333 0.549 0.635
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* Statistically signiﬁcant at p < 0.05.
oxicity and the calculated toxicity (by adding the values
f  each endpoint at corresponding concentrations used in
heir  combinations) demonstrates an additive nature of
heir  combinative cytotoxicity.
Correlation  analysis on the relationship among all the
ndpoints showed that ATP is positively correlated to DNA
ontent,  but negatively correlated to ROS and SRB at a sig-
iﬁcant  level. Both ROS and MMP  are positively correlated
o  SRB (Table 1). Thus, decreased cell viability of HepG2
ells is likely caused by the production of ROS, increased
MP  and decreased ATP and DNA when exposed to AFB1
nd ST. Consistently, the PCA analysis of these endpoints
howed that three clusters can be differentiated: SRB is one
luster,  DNA and ATP content is the second cluster, and the
hird  cluster includes ROS and MMP.  Considering the bio-
hemical  processes associated with mycotoxin exposure,
he  increased intracellular ROS is a common feature for
FB1 or other mycotoxins [34]. The increased intracellular
OS might cause cross-linking of mitochondria membrane
able 2
xperiment design of AFB1 and/or ST concentration.
Inhibition rate (%) AFB1 (mol/L) ST (
10 0.1 0.01 
30  7.5 0.1 
50  17 7.5 e ratio of red (high potential) to blue (low potential) ﬂorescent when
he control).
protein and to induce membrane permeability transition
and  increased MMP  [35]. The increase of MMP  would result
in  a decrease of mitochondrial membrane electrochemical
potential and uncoupling ATP production from mitochon-
drial respiratory chain, which would lead to a reduction of
ATP  production. Experimentally, ATP is the most sensitive
endpoint, and its reduction can be detected in a very early
stage.  Possibilities of ATP consumption (e.g., up-regulation
of detoxiﬁcation genes) to generate non-mitochondria ROS
such  as NADPH oxidase in response to toxic effect of AFB1
and ST might be another pathway for the negative correla-
tion  between ATP and ROS contents.
Although double strand DNA, ATP, ROS content and
MMP  are generally considered as cytotoxicity endpoints,
their intimate relationship with cell viability indicates they
are  also parameters related to cell death program, and
these  endpoints could also be called apoptosis-associated
toxicity endpoints evidenced by literature reports on cell
apoptosis  under high level of ROS such as H2O2 [36] and
MMP  [37] as well double strand DNA breakage [38].
3.2.  Cell cycle, mitochondria membrane potential and
cell  apoptosis
The toxicity endpoints not only reﬂect the biochemi-
cal phenomenon when the HepG2 cell is exposed to AFB1
and ST, but also indicate occurred biological events in the
exposed  cells such as cell cycle arrest and cell apopto-
sis. Apparently, the cell cycle is the basis for cell growth,
and when the cell cycle is arrested, the cellular apoptosis
is  likely the ﬁnal fate for the cell unless the cells can be
recovered through their detoxiﬁcation system.
mol/L) Combination
AFB1 (mol/L) ST (mol/L)
0.1 0.01
5 3.6
10 7.8
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 exposeFig. 6. (A): control. The changes of the apoptosis rate of HepG2 cell after
their  combination of AFB1 + ST (H–J: 0.1 + 0.01, 5 + 3.6, 10 + 7.8 mol/L).
Cell cycle is divided into different phases of G0, G1, S,
G2  and M in which G0 is the quiescent phase, and G1 is the
gap  between G0 and DNA synthesis (S phase) while G2 is
the  gap phase between DNA synthesis and mitotic phase
(M)  for cell division. Different phases of cell cycle are nor-
mally  determined using FCM based on DNA content [28].
In  the current experiment, equivalent toxicity dosages of
AFB1, ST and their combinations were ﬁrst determined by
measuring the SRB at different combinations, and the ﬁnal
result  was tabulated in Table 2. It is noticed that the total
amount of ST and AFB1 in their combinative groups is some-
how  higher than their individual groups at equivalent SRB,
especially  for ST in the combinative groups. The reason for
these  combinations is likely due to their similar chemicald to AFB1 (B–D: 0.1, 7.5, 17 mol/L), ST (E–G: 0.01, 0.1, 7.5 mol/L), and
structure with a common bisdihydrofuran moiety (Fig. 1)
that  might cause them to interfere with each other during
their  uptake by HepG2 cells.
The experimental results from FCM showed that both
AFB1 and ST caused cell cycle arrest at certain stages in a
dose-dependent manner (Fig. 4). For AFB1, most of cells are
in  the stage of S phase and least in the G2/M phase, indi-
cating the cell arrest occurs at the phase of DNA synthesis,
which is consistent with literature report [39]. For ST, most
cells  are stayed at the G0/G1 phase, indicating DNA syn-
thesis  is almost completely inhibited, especially at a high
dose  of ST, which is consistent with the decreased DNA con-
tent  as shown above. For the combinations of AFB1 and ST,
most  cells are stayed at G0/G1 and S phase, which is an
Y. Liu et al. / Toxicology Reports 1 (2014) 1076–1086 1083
Table 3
The  optic density of immunocytochemistry analysis of apoptosis related proteins of Bax and Bcl-2.
Protein SRB Optic density
AFB1 ST AFB1 + ST
Bcl-2
10% 0.167 ± 0.022 0.236 ± 0.037 0.210 ± 0.045
30%  0.165 ± 0.042 0.162 ± 0.042 0.171 ± 0.007
50%  0.16 0 ± 0.030 0.120 ± 0.017 0.156 ± 0.034
Control  0.213 ± 0.044
Bax
10%  0.263 ± 0.04 0.329 ± 0.015 0.328 ± 0.047
30%  0.475 ± 0.035 0.228 ± 0.034 0.245 ± 0.047
50%  0.329 ± 0.062 0.185 ± 0.001 0.215 ± 0.051
Control  0.239 ± 0.009
10%  1.57 ± 0.129 1.39 ± 0.117 1.56 ± 0.164
30%  2.88 ± 0.092 1.40 ± 0.213 1.43 ± 0.137
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early  regulator of cell apoptosis and cytochrome c release
[45],  Caspase-3 as the hallmark of apoptosis [46], and p53
as  the regulator of cytochrome c release from mitochon-
dria [47] were chosen as the representative proteins toBax/Bcl-2
50%  2.05 ± 
Control  
ddition effect of AFB1 and ST. Statistic analysis of the cell
umbers at different stages after treatment by AFB1 and
T  and their combinations with equivalent toxicity (same
RB)  did not show signiﬁcant difference, indicating an addi-
ive  effect of AFB1 and ST on cell cycle arrest. As what has
een  shown previously that mitochondrion is highly asso-
iated  with cell viability, especially the MMP.  Here, the
itochondria membrane potential based on JC-1 dye [40]
as  further analyzed. The ratio between red (high poten-
ial)  and blue (lower potential) ﬂorescent intensity reﬂects
he  mitochondria functionality in HepG2 cells affected by
FB1 and ST (Fig. 5). Apparently, all the treatment led to a
ransition from red to blue ﬂorescent indicating decreased
embrane potential in a dose-dependent manner. The fact
hat  the combination of AFB1 and ST did not show signif-
cant difference with the other individual groups at the
ame  toxicity level showed additive effect of AFB1 and ST
n  the mitochondria membrane potential. The decreased
itochondria membrane potential, as the biomarker of
xidative  stress [41], is a direct result of increased MMP
42],  which is consistent with the cytotoxicity endpoint
esults of increased ROS and MMP.
Mitochondria is the central player in cell apoptosis [43],
nd  a decreased mitochondria membrane potential as well
s  increased membrane permeability would result in a
elease  of proteins such as cytochrome c to activate cas-
ase  cascade and programmed cell death [44]. Thus, the
poptosis of HepG2 cell upon exposing to AFB1 and ST
as  studied by FCM employing double staining reagents
f  propidium iodide (PI) and Annexin V labeled by ﬂuo-
escein of isothiocyanatc (FITC) (green ﬂuorescence) that
an  discriminate intact cells (FITC−/PI−) from apoptotic
FITC+/PI−) or necrotic cells (FITC+/PI+). The viable cell is
resent in the lower left quadrants (LLQ) of the panels
hile non-viable, necrotic cells are shown in the upper
ight  quadrants (URQ), and the apoptotic cells are shown in
he  lower right quadrants (LRQ). The experimental results
Fig.  6) showed that most of the cells in the control sample
Fig.  6A) are present in the LLQ regions, and for samples
reated by AFB1 (Fig. 6B–D) and the combinations of AFB1
nd ST (Fig. 6H–J), the cell number in the LRQ regions
ncreased in a dose-dependent manner. For ST treatment
Fig. 6E–G), the cell apoptosis occurs even at a very low1.54 ± 0.141 1.37 ± 0.234
1.12 ± 0.187
concentration. With the trend of more cells present in the
separation region between URQ and LRQ as the increase
of  cell number in LRQ regions (more evident in the group
of  AFB1 + ST), the cells in the separation region might be
regarded as apoptotic cells in their late stages. Thus, the
total  apoptotic cells include the cells at LRQ and those in
the  separation region of URQ and LRQ, and when taking
them together (Fig. 7), all the treatments induced apopto-
sis  of HepG2 cells. Although the apoptosis rate is increased
along the concentration of the mycotoxins (except ST), no
signiﬁcant  difference was found among groups (paired t-
test)  with equivalent toxicity indicating an additive nature
of  AFB1 and ST on cell apoptosis.
3.3.  Immunocytochemistry analysis of HepG2 apoptosis
FCM analysis by employing many different DNA staining
dyes clearly showed cell cycle arrest, decreased mitochon-
dria membrane potential, and cell apoptosis. In order to
further  conﬁrm these results, the examination of apopto-
sis  related proteins was  carried out. Bax and Bcl-2 as theFig. 7. The apoptosis rate of HepG2 cell induced by AFB1 and ST as well
as their combinations. The x-axis is the corresponding dosage that can
induce the labeled cell viability inhibition. 0.1% DMSO is the control.
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Fig. 8. Immunocytochemistry study on the expressions of apoptosis related proteins of Bax (top-left), Bcl-2 (top-right), Caspase-3 (bottom-left), and p53
e group(bottom-right)  at a treatment dosage leading to 50% cell viability for all th
reader  is referred to the web version of this article.)
analyze cell apoptosis upon exposed to AFB1, ST and their
combinations. Immunocytochemistry was selected as the
method  since the distribution of apoptosis-related pro-
teins  have different locations in the cell, and the analysis of
these  proteins in a cell context can be used to validate the
event  of cell apoptosis as well as to observe morphological
changes of cells upon exposure to mycotoxins. However,
the  optical density of the proteins obtained though imag-
ing  analysis can only be used as a reference reﬂecting the
trend  of changes. In another word, the immunocytochem-
istry analysis is considered as a semi-quantitative method
to  evaluate the relative changes of protein expressions.s was  presented. (For interpretation of the references to color in text, the
Mitochondria is an important player in cell apoptosis
[45] with its apoptosis-associated BCL2 family proteins
including Bax and Bcl-2. Bax promotes the release of
cytochrome c [48] that is important to the activation of
caspase  cascade [49] while Bcl-2 is anti-apoptotic by reg-
ulating  the activity of Bax. In normal cells, there exists a
balance  between these pro- and anti-apoptotic proteins,
and  a disruption of this balance often results in some patho-
logical  conditions such as human autosomal-dominant
polycystic kidney disease with down-regulated Bcl-2 [50].
Thus  the ratio of Bax and Bcl-2 might be more important to
evaluate  cell Apoptosis [51]. In the current investigation,
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cl-2 showed a dose-dependent decrease of its content,
nd Bax, except the 10% dosage with an increased content,
lso  showed a decreased expression compared to the con-
rol  (Table 3). It looks like that both Bax and Bcl-2 from
maging analysis showed a decrease as the increase of the
oncentration of AFB1 and ST, but the ratio of Bax and Bcl-2
ith  a value from 1.37 to 2.88 in the treatment group is
igher  than the control group of 1.12, supporting the pro-
poptotic  function of Bax and Bcl-2 to HepG2 cells upon
xposed to mycotoxins. The decreased signal of Bax at high
evel  exposure to mycotoxin is probably due to the degra-
ation  of Bax since the induced cytochrome c release by
ax  is the earliest event occurred during cell apoptosis, and
ith  high rate of cell apoptosis at high dosage (more dead
ells  at the later phase of apoptosis), the Bax protein might
ave  been degraded by the caspase cascade leading to a
ecreased signal of Bax after 2-days treatment. As for Bcl-
,  the decreased signal along the dosage might be caused by
 lower expression of Bcl-2 as what has been shown in the
iterature [52]. The immunocytochemistry image (Fig. 8) at
0%  cell growth inhibition showed the brownish color of
ax  and Bcl-2 in the cytosol with a blue nucleus conﬁrmed
he  expression of both Bax and Bcl-2 proteins.
The occurrence of cell apoptosis is also supported by
mmunocytochemistry study of other apoptosis protein
f  Caspase-3 and p53 (Fig. 8). Compared to the control,
oticeable increase of protein signals (brown color in cyto-
ol)  was shown for Caspase-3. Speciﬁcally, ST treatment
howed increased optic density as the increase of dosage,
ut  AFB1 showed an increase from 10% to 30% SRB, and
ecreased signal from 30% to 50% SRB, and the combinative
attern is more close to AFB1. For p53, the dose-optic den-
ity  (expressed in nucleus) relationship showed a better
rend  as the increase of dosage for all the treatments, which
ndicates the involvement of p53 in the process of cell
poptosis. Considering the increased MMP  and decreased
embrane potential of mitochondria, and literature report
53],  the process of apoptosis of HepG2 cells upon exposure
o  mycotoxins is likely a p53-dependent intrinsic process.
.  Conclusion
The co-proapoptotic cytotoxicity of AFB1 and ST has
een examined from apoptosis associated endpoints, cell
ycle  arrest, mitochondria integrity, and apoptosis related
roteins. Due to the additive nature of AFB1 and ST to
ytotoxicity endpoints, cell cycle arrest distribution, apo-
tosis  rate and membrane potential of mitochondria, AFB1
nd ST might additively promote the apoptosis of HepG2
ells.  Although there have been many methods to reduce
he  level of mycotoxin contamination in food products or
ngredients through physical, chemical or biological meth-
ds,  consumption of mycotoxin-contaminated foods might
e  inevitable, especially in regions with high growth of
ycotoxin-producing fungi, and mechanism-based pre-
entive  or interventive measure to reduce the in vivo
oxicity of mycotoxin might be one strategy worth of
urther investigating. The current study showed that the
itochondria in the cell is one of the targets of AFB1 and
T,  which indicates some mitochondria-protective func-
ional  component might be used to protect the integrity of
[
[s 1 (2014) 1076–1086 1085
cells.  Actually, there have been related reports such as the
mitochondria-target functional peptide that has been used
as  neuroprotective agents [54] and antioxidant functional
compounds to reduce the toxicity of mycotoxins [55]. Addi-
tionally,  the additive effect of AFB1 and ST combinations on
cell  apoptosis also provides scientiﬁc basis for food safety
regulations to reduce the potential health risk associated
with additive toxicity of coexisted mycotoxins in feeds and
foods.
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